[{"address1": "3060 Pegasus Park Drive", "address2": "Building 6", "city": "Dallas", "state": "TX", "zip": "75247", "country": "United States", "phone": "310 618 6994", "website": "https://www.fortebiorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul A.  Wagner Ph.D.", "age": 54, "title": "CEO, President & Chairman", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1030848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Antony A. Riley CPA", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 652090, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara K. Finck M.D.", "age": 77, "title": "Chief Medical Clinician & Director", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 488057, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Roenfeldt", "title": "Chief Operating Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.49, "open": 14.27, "dayLow": 14.0598, "dayHigh": 18.0, "regularMarketPreviousClose": 14.49, "regularMarketOpen": 14.27, "regularMarketDayLow": 14.0598, "regularMarketDayHigh": 18.0, "payoutRatio": 0.0, "forwardPE": -0.9846575, "volume": 86647, "regularMarketVolume": 86647, "averageVolume": 88873, "averageVolume10days": 63550, "averageDailyVolume10Day": 63550, "bid": 17.46, "ask": 18.17, "bidSize": 1, "askSize": 1, "marketCap": 225109008, "fiftyTwoWeekLow": 4.9, "fiftyTwoWeekHigh": 28.68, "allTimeHigh": 6732.375, "allTimeLow": 4.11, "fiftyDayAverage": 13.1812, "twoHundredDayAverage": 10.410215, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 131639496, "profitMargins": 0.0, "floatShares": 10295853, "sharesOutstanding": 12526935, "sharesShort": 472924, "sharesShortPriorMonth": 173022, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.038, "heldPercentInsiders": 0.04935, "heldPercentInstitutions": 0.83773005, "shortRatio": 4.84, "shortPercentOfFloat": 0.045100003, "impliedSharesOutstanding": 12526935, "bookValue": 6.715, "priceToBook": 2.676098, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -51742000, "trailingEps": -0.08, "forwardEps": -18.25, "lastSplitFactor": "1:25", "lastSplitDate": 1724803200, "enterpriseToEbitda": -2.466, "52WeekChange": 0.069372654, "SandP52WeekChange": 0.1276468, "quoteType": "EQUITY", "currentPrice": 17.97, "targetHighPrice": 75.0, "targetLowPrice": 19.0, "targetMeanPrice": 52.25, "targetMedianPrice": 57.5, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 93414000, "totalCashPerShare": 7.459, "ebitda": -53382000, "totalDebt": 0, "quickRatio": 7.19, "currentRatio": 7.344, "returnOnAssets": -0.58066005, "returnOnEquity": -1.10722, "freeCashflow": -26676124, "operatingCashflow": -44425000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "FBRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.08, "epsForward": -18.25, "epsCurrentYear": -4.4575, "priceEpsCurrentYear": -4.031408, "fiftyDayAverageChange": 4.7887993, "fiftyDayAverageChangePercent": 0.36330527, "twoHundredDayAverageChange": 7.559784, "twoHundredDayAverageChangePercent": 0.726189, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 24.0166, "regularMarketPrice": 17.97, "shortName": "Forte Biosciences, Inc.", "longName": "Forte Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1492090200000, "postMarketChangePercent": -0.05564958, "postMarketPrice": 17.96, "postMarketChange": -0.010000229, "regularMarketChange": 3.48, "regularMarketDayRange": "14.0598 - 18.0", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 88873, "fiftyTwoWeekLowChange": 13.07, "fiftyTwoWeekLowChangePercent": 2.6673467, "fiftyTwoWeekRange": "4.9 - 28.68", "fiftyTwoWeekHighChange": -10.710001, "fiftyTwoWeekHighChangePercent": -0.373431, "fiftyTwoWeekChangePercent": 6.9372654, "dividendDate": 1592265600, "marketState": "PREPRE", "corporateActions": [], "postMarketTime": 1763513849, "regularMarketTime": 1763499602, "exchange": "NCM", "messageBoardId": "finmb_594626683", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Forte Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-11-19"}]